Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Varret

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|May 2, 2023
Additive Effect of <i>APOE</i> Rare Variants on the Phenotype of Familial HypercholesterolemiaOriane Marmontel, Yara Abou-Khalil, Olivier Bluteau, et al.
Orphanet Journal of Rare Diseases|January 18, 2011
Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease)Amandine Georges, Jessica Bonneau, Dominique Bonnefont-Rousselot, et al.
European Journal of Human Genetics : EJHG|January 28, 2018
Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?Youmna Ghaleb, Sandy Elbitar, Petra El Khoury, et al.
Scientific Reports|February 2, 2018
New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant HypercholesterolemiaSandy Elbitar, Delia Susan-Resiga, Youmna Ghaleb, et al.
European Journal of Human Genetics : EJHG|June 24, 2010
A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1Alice Marques-Pinheiro, Marie Marduel, Jean-Pierre Rabès, et al.
Journal of Clinical Lipidology|October 27, 2018
Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1Petra El Khoury, Philippe Couvert, Sandy Elbitar, et al.
Metabolites|September 26, 2021
Identification of a Variant in <i>APOB</i> Gene as a Major Cause of Hypobetalipoproteinemia in Lebanese FamiliesCarine Ayoub, Yara Azar, Yara Abou-Khalil, et al.
International Journal of Molecular Sciences|May 28, 2022
<i>APOE</i> Molecular Spectrum in a French Cohort with Primary DyslipidemiaYara Abou Khalil, Oriane Marmontel, Jean Ferrières, et al.
Atherosclerosis|May 15, 2026
PCSK9 expression in human atherosclerotic lesions and vascular smooth muscle cellsYara Azar, Yara Abou Khalil, Marie-Nathalie Lebel, et al.
The Journal of Biological Chemistry|September 11, 2004
NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterolSuzanne Benjannet, David Rhainds, Rachid Essalmani, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Arteriosclerosis, Thrombosis, and Vascular Biology|May 2, 2023
Additive Effect of <i>APOE</i> Rare Variants on the Phenotype of Familial HypercholesterolemiaOriane Marmontel, Yara Abou-Khalil, Olivier Bluteau, et al.
Orphanet Journal of Rare Diseases|January 18, 2011
Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease)Amandine Georges, Jessica Bonneau, Dominique Bonnefont-Rousselot, et al.
European Journal of Human Genetics : EJHG|January 28, 2018
Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?Youmna Ghaleb, Sandy Elbitar, Petra El Khoury, et al.
Scientific Reports|February 2, 2018
New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant HypercholesterolemiaSandy Elbitar, Delia Susan-Resiga, Youmna Ghaleb, et al.
European Journal of Human Genetics : EJHG|June 24, 2010
A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1Alice Marques-Pinheiro, Marie Marduel, Jean-Pierre Rabès, et al.
Journal of Clinical Lipidology|October 27, 2018
Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1Petra El Khoury, Philippe Couvert, Sandy Elbitar, et al.
Metabolites|September 26, 2021
Identification of a Variant in <i>APOB</i> Gene as a Major Cause of Hypobetalipoproteinemia in Lebanese FamiliesCarine Ayoub, Yara Azar, Yara Abou-Khalil, et al.
International Journal of Molecular Sciences|May 28, 2022
<i>APOE</i> Molecular Spectrum in a French Cohort with Primary DyslipidemiaYara Abou Khalil, Oriane Marmontel, Jean Ferrières, et al.
Atherosclerosis|May 15, 2026
PCSK9 expression in human atherosclerotic lesions and vascular smooth muscle cellsYara Azar, Yara Abou Khalil, Marie-Nathalie Lebel, et al.
The Journal of Biological Chemistry|September 11, 2004
NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterolSuzanne Benjannet, David Rhainds, Rachid Essalmani, et al.
Pageof 6